Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Catalyst Pharmaceuticals Inc CPRX

Healthcare Biotechnology
Catalyst Pharmaceuticals, Inc. is a commercial-stage biopharmaceutical company. The Company is focused on developing and commercializing first-in-class medicines that address rare and difficult to treat diseases. Its flagship commercial product is FIRDAPSE (amifampridine) tablets 10 milligrams (mg), approved for the treatment of Lambert-Eaton Myasthenic Syndrome (LEMS) for adults and for... see more

Recent & Breaking News (NDAQ:CPRX)

Catalyst Pharmaceuticals to Present at the Piper Jaffray 26th Annual Healthcare Conference

GlobeNewswire December 1, 2014

Catalyst Pharmaceuticals Announces Notice of Allowance of U.S. Patent Application for the Reduction or Elimination of Visual Field Defects by Treating Patients With CPP-115

GlobeNewswire November 24, 2014

Catalyst Pharmaceuticals Announces Third Quarter 2014 Financial Results

GlobeNewswire November 14, 2014

Catalyst Pharmaceuticals Announces Proposed Settlement of Pending Securities Class Action Lawsuit

GlobeNewswire November 4, 2014

Catalyst Pharmaceuticals Appoints David J. Caponera as Vice President Patient Advocacy and Reimbursement

GlobeNewswire October 28, 2014

Catalyst Pharmaceuticals to Present Firdapse Phase 3 Trial Results at the 61st Annual Meeting of the American Association of Neuromuscular and Electrodiagnostic Medicine

GlobeNewswire October 27, 2014

Catalyst Pharmaceuticals to Present Top-Line Safety and Efficacy Results From Phase 3 Firdapse Trial at 139th Annual Meeting of the American Neurological Association

GlobeNewswire October 8, 2014

Catalyst Pharmaceuticals to Present at 13th Annual BIO Investor Forum

GlobeNewswire October 2, 2014

Catalyst Pharmaceuticals Announces Positive Top-Line Phase 3 Data From Pivotal Firdapse Clinical Trial in Patients With Lambert-Eaton Myasthenic Syndrome (LEMS)

GlobeNewswire September 29, 2014

Catalyst Pharmaceuticals Appoints David D. Muth as Executive Vice President, Corporate Development

GlobeNewswire September 4, 2014

Catalyst Pharmaceutical Partners to Present at Rodman & Renshaw's 16th Annual Global Investment Conference

GlobeNewswire September 3, 2014

Catalyst Pharmaceutical Partners Initiates Phase 1(b) Safety and Tolerance Study for CPP-115

GlobeNewswire September 2, 2014

Catalyst Pharmaceutical Partners Announces Second Quarter 2014 Financial Results

GlobeNewswire August 14, 2014

Catalyst Pharmaceutical Partners Provides Updates on Progress of Phase 3 Firdapse Study in Patients With Lambert-Eaton Myasthenic Syndrome (LEMS)

GlobeNewswire August 11, 2014

Rodman & Renshaw 2014 Annual Global Investment Conference to be held in New York from September 8 to 10, 2014

Business Wire August 11, 2014

Catalyst Pharmaceutical Partners to Present at the JMP Securities 2014 Healthcare Conference

GlobeNewswire June 19, 2014

Catalyst Pharmaceutical Partners Set to Join Russell Microcap(R) Index

GlobeNewswire June 18, 2014

Catalyst Pharmaceutical Partners to Present at the Jefferies 2014 Global Healthcare Conference

GlobeNewswire May 29, 2014

Catalyst Pharmaceutical Partners Announces First Quarter 2014 Financial Results and Provides Corporate Update

GlobeNewswire May 16, 2014

The Shuman Law Firm Investigates Catalyst Pharmaceutical Partners, Inc.

Business Wire May 15, 2014